Last updated on December 2016

A Phase 3, double blind, randomized study of RVT-101 versus placebo when added to existing stable donepezil treatment in subjects with mild to moderate Alzheimer’s disease; RVT-101-3001


Brief description of study

A Phase 3, double blind, randomized study of RVT-101 versus placebo when added to existing stable donepezil treatment in subjects with mild to moderate Alzheimer’s disease; RVT-101-3001

Detailed Study Description

This Study is for patients that have mild to moderate Alzheimer's disease that are on a stable therapy with donepezil.

Clinical Study Identifier: TX146483

Contact Investigators or Research Sites near you

Start Over

Bonita Waites

Parker Jewish Institute
New Hyde Park, NY USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.